⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ondine Biomedical Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Ondine Biomedical Inc.
↗Vancouver, Canada
Ondine Biomedical is a Canadian life sciences company pioneering light-activated antimicrobial therapies, known as photodisinfection. The company's platform technology uses a non-thermal, light-activated photosensitizer to rapidly destroy bacteria, viruses, and fungi, including drug-resistant pathogens, without contributing to antimicrobial resistance (AMR).
Its lead product, Steriwave, is a nasal decolonization therapy used to prevent healthcare-associated infections (HAIs), including surgical site infections. The company is actively expanding its pipeline to address other clinical needs such as chronic rhinosinusitis, ventilator-associated pneumonia, and wound/burn decolonization.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Medical Devices / Antimicrobial Therapies
SIZE & FINANCIALS
Employees:1-50
Ownership:public
Status:operating
FUNDING
Stage:Public
STOCK
Exchange:LSE
Ticker:OBI
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Steriwave)
Modalities:Photodisinfection (aPDT)
Active Trials:1
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Mölnlycke (Distribution partnership for UK/EU/Middle East)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Carolyn Cross - CEO
Nicolas Loebel - President and CTO
Michael S. Behlke - CFO and COO
Board Members:Jean Charest (Chairman), Carolyn Cross, Nicolas Loebel, Jean Duvall, Junaid Bajwa, Margaret Shaw
LINKS
Website:ondinebio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ondine Biomedical Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.